Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Allergen describes compounds with retinoid-like activity

Sep. 6, 1996

Interferon gamma-1b enters pivotal trials for atopic dermatitis

Sep. 6, 1996

ProCyte cleared for clinical trials with wound-healing product

Sep. 6, 1996

ProCyte issued patents covering hair loss applications

Sep. 6, 1996

Ornithine decarboxylase inhibitors for dermatology

Sep. 6, 1996

Xoma/Genentech to commence clinical trials with humanized monoclonal antibody

Sep. 6, 1996

ADCON-L and ADCON-T/N research demonstrates efficacy

Aug. 30, 1996

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Sepracoat given European Approval of Conformity Certificate

Aug. 30, 1996

Repel proved effective in preclinical studies

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...